Similar articles for PMID: 19217525

Year	Number of Results
1998	1
2002	3
2003	3
2004	3
2005	3
2006	1
2007	6
2008	8
2009	15
2010	10
2011	13
2012	6
2013	8
2014	17
2015	7
2016	6
2017	4
2018	4
2019	6
2020	3
2021	2
2022	3
2023	2
2024	0

1

Tumor targeting and SPECT imaging properties of an (111)In-labeled galectin-3 binding peptide in prostate carcinoma.

Deutscher SL, Figueroa SD, Kumar SR. Deutscher SL, et al. Nucl Med Biol. 2009 Feb;36(2):137-46. doi: 10.1016/j.nucmedbio.2008.10.015. Nucl Med Biol. 2009. PMID: 19217525

2

111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.

Kumar SR, Deutscher SL. Kumar SR, et al. J Nucl Med. 2008 May;49(5):796-803. doi: 10.2967/jnumed.107.048751. Epub 2008 Apr 15. J Nucl Med. 2008. PMID: 18413389 Free article.

3

In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.

Kumar SR, Gallazzi FA, Ferdani R, Anderson CJ, Quinn TP, Deutscher SL. Kumar SR, et al. Cancer Biother Radiopharm. 2010 Dec;25(6):693-703. doi: 10.1089/cbr.2010.0820. Cancer Biother Radiopharm. 2010. PMID: 21204764 Free PMC article.

4

Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.

Kumar SR, Quinn TP, Deutscher SL. Kumar SR, et al. Clin Cancer Res. 2007 Oct 15;13(20):6070-9. doi: 10.1158/1078-0432.CCR-07-0160. Clin Cancer Res. 2007. PMID: 17947470

5

Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice.

Ho CL, Chen LC, Lee WC, Chiu SP, Hsu WC, Wu YH, Yeh CH, Stabin MG, Jan ML, Lin WJ, Lee TW, Chang CH. Ho CL, et al. Cancer Biother Radiopharm. 2009 Aug;24(4):435-43. doi: 10.1089/cbr.2008.0616. Cancer Biother Radiopharm. 2009. PMID: 19694578

6

[^99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers.

Vats K, Chakraborty A, Rakshit S, Damle A, Sarma HD, Satpati D. Vats K, et al. Nucl Med Biol. 2023 Mar-Apr;118-119:108331. doi: 10.1016/j.nucmedbio.2023.108331. Epub 2023 Mar 10. Nucl Med Biol. 2023. PMID: 36933456

7

In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas.

Deutscher SL, Figueroa SD, Kumar SR. Deutscher SL, et al. J Labelled Comp Radiopharm. 2009 Dec 1;52(14):583-590. doi: 10.1002/jlcr.1691. J Labelled Comp Radiopharm. 2009. PMID: 20976123 Free PMC article.

8

(64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.

Kumar SR, Gallazzi FA, Quinn TP, Deutscher SL. Kumar SR, et al. J Nucl Med. 2011 Nov;52(11):1819-26. doi: 10.2967/jnumed.111.093716. Epub 2011 Oct 7. J Nucl Med. 2011. PMID: 21984800 Free article.

9

Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.

Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS. Chen X, et al. J Nucl Med. 2004 Oct;45(10):1776-83. J Nucl Med. 2004. PMID: 15471848 Free article.

10

¹¹¹In-Tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-(GSG)-ANTPCGPYTHDCPVKR.

Leung K. Leung K. 2009 Apr 17. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2009 Apr 17. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641412 Free Books & Documents. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

118 results

Results by year